Your browser doesn't support javascript.
loading
Microbiologic outcomes of ceftazidime-avibactam dosing in patients with sepsis utilizing renal replacement therapies.
El Nekidy, Wasim S; Al Ali, Mooza; Abidi, Emna; Ghazi, Islam M; Attallah, Nizar; El Lababidi, Rania; Mooty, Mohamad; Ghosn, Muriel; Mallat, Jihad.
Afiliación
  • El Nekidy WS; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
  • Al Ali M; Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
  • Abidi E; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
  • Ghazi IM; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
  • Attallah N; Arnold and Marie Schwartz College of Pharmacy, Long Island University, Brookville, New York, USA.
  • El Lababidi R; Department of Nephrology, Nephrology Associates of Kentuckiana, Louisville, Kentucky, USA.
  • Mooty M; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
  • Ghosn M; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
  • Mallat J; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
Hemodial Int ; 27(3): 289-295, 2023 07.
Article en En | MEDLINE | ID: mdl-37144742

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía / Bacteriemia Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía / Bacteriemia Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2023 Tipo del documento: Article